What happened. Shares of Britain-based drug company GlaxoSmithKline (NYSE:GSK) dropped 12.4% in February, according to data provided by S&P Global Market Intelligence. Coronavirus fears were responsible for some of the drop, but not all. The company also reported quarterly earnings that didn't please investors.